Company

Stemirna Therapeutics Halts mRNA Vaccine Factory Construction Amid Low Demand

CompanyDeals

BGI Genomics Partners with Thai Entities to Combat Thalassemia through Genomics and Cell Therapy

CompanyDrug

Shanghai Junshi Biosciences’ Tuoyi Receives NMPA Review for ES-SCLC Treatment

CompanyLegal / IP

Sichuan Gowell Pharmaceutical Wins Reversal in Forxiga Patent Infringement Case

CompanyDeals

Boyu Capital Acquires Hong Kong Medical Device Company Quasar for Over $600 Million

Company

Novartis Q2 2023 Results Exceed Expectations with 9% YOY Sales Growth

CompanyDeals

Shanghai Pharmaceuticals and Mindray Form Strategic Alliance for Medical Equipment and IVD Products

CompanyDeals

MindRank Ltd Secures Over $20 Million in Series A+ Funding to Advance AI Drug Development

CompanyDeals

Zhejiang Dian Diagnostics Partners with Northeast Infectious Diseases Alliance to Enhance Surveillance

CompanyDeals

Novartis Acquires DTx Pharma and Its FALCON Technology for Up to $1 Billion

CompanyDeals

Allen Institute for Immunology Partners with Eli Lilly to Study Atopic Dermatitis and Rheumatoid Arthritis

CompanyDeals

Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development